Stepan Company (SCL)

Stepan Company is a common stock listing on the NYSE representing the shares of an operating company in the materials sector. Through its subsidiaries, the company develops and sells specialty and intermediate chemicals used by other manufacturers in a range of end markets in the United States, Europe, Latin America, and other international regions. Its business is organized into three segments: Surfactants, Polymers, and Specialty Products.

The Surfactants segment supplies ingredients used in cleaning, disinfection, personal care, agricultural, and industrial applications. The Polymers segment provides polyurethane polyols, polyester resins, specialty polyols, and phthalic anhydride for uses that include insulation, coatings, adhesives, sealants, elastomers, and construction-related materials. The Specialty Products segment focuses on flavors, emulsifiers, and solubilizers used in food, nutritional supplement, flavoring, and pharmaceutical applications. Founded in 1932 and headquartered in Northbrook, Illinois, Stepan Company operates as a diversified chemical producer with a broad industrial and consumer customer base.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-SCL
$65.12
-4.0% Downside
Fair
$85
25.3% Upside
Undervalued
Good
December 1, 2026
December 15, 2026
2.3%
February 18, 2027
356.9x
1.3x
0.6x
1.543 B
2.079 B
28.3%
94.3%
2.1
-1,341.8%
846.4%
Valuation • Fair Value

Stepan Company (NYSE-SCL) Fair Value by Valuation Model

Review the available estimates for Stepan Company (NYSE-SCL), including DCF Fair Value, Ben Graham Formula Value, DDM Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$65.12

Estimated downside of 4.0% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$68.54

Discounted cash flow valuation reference.

Ben Graham Formula Value

$2.11

Classic Ben Graham valuation formula reference.

DDM Fair Value

$62.80

Dividend discount model valuation reference.

Comps Fair Value

$62.49

Comparable-company valuation reference.

Analyst Price Target

$85

Analysts imply upside of 25.3%.

How to read these valuation models

Use the 7 available valuation references for Stepan Company (NYSE-SCL) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Stepan Company (NYSE-SCL)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

2.535 B

Current operating scale indicator.

Revenue Forecast

2.532 B

Forward revenue estimate.

EBITDA

214.9 M

Current operating profitability reference.

EBITDA Forecast

235.3 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Stepan Company (NYSE-SCL) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Stepan Company (NYSE-SCL)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.55

No elevated caution signal from this screen.

Altman Z-Score

2.1

Intermediate risk zone.

FCF / Net Income

846.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Stepan Company (NYSE-SCL). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Stepan Company (NYSE-SCL)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

February 18, 2027

Days to Earnings

104

Dividend Payment Date

December 15, 2026

Ex-Dividend Date

December 1, 2026

Dividend Yield

2.3%

Current income yield reference.

Payout Ratio

-1,341.8%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Stepan Company (NYSE-SCL), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Stepan Company (NYSE-SCL) Stock Forecast & Technical Outlook

Review Stepan Company (NYSE-SCL) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Stepan Company (NYSE-SCL) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Stepan Company (NYSE-SCL) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Stepan Company (NYSE-SCL) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Stepan Company (NYSE-SCL) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Buy

The monthly technical read for Stepan Company (NYSE-SCL) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Stepan Company (NYSE-SCL)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Stepan Company (NYSE-SCL) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ • Fast Investor Answers

Stepan Company (NYSE-SCL) Stock FAQ

Data-supported answers about Stepan Company (NYSE-SCL), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$65.12
Estimated downside 4.0%
Valuation Rating
Overvalued
Estimated downside of 4.0%
Analyst Target
$85
Implied upside 25.3%
Financial Health
Good
Current financial-health read

The current fair value estimate for Stepan Company (NYSE-SCL) is $65.12. This implies an estimated downside of 4.0% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 4.0% versus the current market price.

The available analyst price target for Stepan Company (NYSE-SCL) is $85. The analyst target implies estimated upside of 25.3%.

The current financial health read for Stepan Company (NYSE-SCL) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Stepan Company (NYSE-SCL) is February 18, 2027.

Based on the current data, dividend yield is 2.3%, ex-dividend date is December 1, 2026, payment date is December 15, 2026.

The current P/E ratio listed for Stepan Company (NYSE-SCL) is 356.9x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Stepan Company is 1.543 B.

The current enterprise value listed for Stepan Company is 2.079 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Stepan Company is NYSE-SCL, and the stock is listed on NYSE.

Stepan Company (NYSE-SCL) is listed on NYSE.

The current debt-to-total-capital ratio listed for Stepan Company is 28.3%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Stepan Company is 94.3%. Free float helps investors understand how much of the share base is available for public trading.